Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: A case-control study

Brain and Development

Volumn 29, Issue 8, 2007, Pages 510-513

  Marui, Tetsuya ^a   Funatogawa, Ikuko ^b   Koishi, Shinko ^c   Yamamoto, Kenji ^d   Matsumoto, Hideo ^e   Hashimoto, Ohiko ^f   Nanba, Eiji ^g   Nishida, Hisami ^h   Sugiyama, Toshiro ^c   Kasai, Kiyoto ^a   Watanabe, Keiichiro ⁱ   Kano, Yukiko ⁱ   Kato, Nobumasa ^a   Sasaki, Tsukasa ^a,j  

^a UNIVERSITY OF TOKYO   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f AINO UNIVERSITY   (Japan)

^g TOTTORI UNIVERSITY   (Japan)

^h Asunaro Hospital for Child and Adolescent Psychiatry   (Japan)

ⁱ UNIVERSITY OF TOKYO   (Japan)

^j UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Autistic disorder; Chromosome 7; Genetic association; Glutamate system; Haplotype block; TAC1

Indexed keywords

GLUTAMIC ACID; NEUROKININ; SUBSTANCE P; TACHYKININ;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CHROMOSOME 7Q; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; HAPLOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM; SYNAPTIC TRANSMISSION;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TACHYKININS;

EID: 34547668725     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.braindev.2007.01.010     Document Type: Article

References (15)

1. Folstein S.E., and Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet 2 (2001) 943-955
2. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25 (1995) 63-77
3. Steffenburg S., Gillberg C., Hellgren L., Andersson L., Gillberg I.C., Jakobsson G., et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30 (1989) 405-416
4. Ramoz N., Reichert J.G., Smith C.J., Silverman J.M., Bespalova I.N., Davis K.L., et al. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 161 (2004) 662-669
5. Serajee F.J., Zhong H., Nabi R., and Huq A.H. The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 40 (2003) e42
6. Cao Y.Q., Mantyh P.W., Carlson E.J., Gillespie A.M., Epstein C.J., and Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392 (1998) 390-394
7. Zhang J.P., Wei L.C., Cao R., and Chen L.W. Differential co-expression of AMPA receptor subunits in substance P receptor-containing neurons of basal forebrain regions of C57/BL mice. Neurochem Int 49 (2006) 319-326
8. Bilkei-Gorzo A., Racz I., Michel K., and Zimmer A. Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 22 (2002) 10046-10052
9. Vargas D.L., Nascimbene C., Krishnan C., Zimmerman A.W., and Pardo C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57 (2005) 67-81
10. Izutsu T., Osada H., Tachimori H., Naganuma Y., Kato S., and Kurita H. The usefulness of the child behavior questionnaire revised (CBQ-R) as a supplementary scale for diagnosis of pervasive developmental disorders. Rinsyo-Seishin Igaku 30 (2001) 525-532 in Japanese
11. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., et al. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 9 (2004) 1007-1029
12. Krause J.E., Chirgwin J.M., Carter M.S., Xu Z.S., and Hershey A.D. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA 84 (1987) 881-885
13. Deguchi K., Antalffy B.A., Twohill L.J., Chakraborty S., Glaze D.G., Armstrong D.D., et al. immunoreactivity in Rett syndrome. Pediatr Neurol 22 (2000) 259-266
14. Matsuishi T., Nagamitsu S., Yamashita Y., Murakami Y., Kimura A., Sakai T., et al. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome. Ann Neurol 42 (1997) 978-981
15. Szatmari P., Jones M.B., Zwaigenbaum L., and MacLean J.E. Genetics of autism: overview and new directions. J Autism Dev Disord 28 (1998) 351-368